SciFiMed

This multi-disciplinary project will combine fundamental immunological research with novel nanomaterial-based biosensor development translated into proof-of-principle diagnostics to revolutionize doctors’ ability to diagnose and treat severe inflammatory diseases plaguing millions of Europeans. SciFiMed will 1) investigate the pathophysiology of the FH-protein family, to enable 2) the development of personalized, radically new on-time diagnostics, which allow 3) improved patient stratification for prospective cohort studies to understand complement-associated diseases. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899163.